As shown in Figure 6(a), according to the results of the Timer algorithm, HCC patients in the high-risk score subgroup had modestly increased ratios of B cells, CD4+ T cells, neutrophils, and myeloid dendritic cells. The gene discussed is CD4; the disease is hepatocellular carcinoma.